Jim Cramer has raised concerns over the constitutionality of recent drug price controls, urging pharmaceutical companies to seek an injunction.
What Happened: CNBC’s Mad Money host, Cramer, in a post on X on Monday, argued that, unlike tariffs, drug price controls fall under the Commerce Clause of the Constitution and suggested they may not hold up under legal scrutiny.
This follows President Donald Trump’s May 12, 2025, announcement to align U.S. drug prices with lower international …